highly significantP < 0.001
The log‐rank test indicated a highly significant difference ( P < 0.001).
The log‐rank test indicated a highly significant difference ( P < 0.001).
A directionally favorable effect for GLP‐1 RA use persisted across these subgroups, even in instances where the estimated HR did not reach statistical significance, suggesting broadly consistent benefits across clinically relevant patient strata.